Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): The Association of Genetic Biomarkers and Hereditary Hemochromatosis, DD11-008, Initial Review, 3908 [2011-1236]

Download as PDF 3908 Federal Register / Vol. 76, No. 14 / Friday, January 21, 2011 / Notices be submitted by e-mail to DCAS@CDC.GOV. John Howard, Director, National Institute for Occupational Safety and Health. [FR Doc. 2011–1228 Filed 1–20–11; 8:45 am] Dated: January 7, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–1236 Filed 1–20–11; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): The Association of Genetic Biomarkers and Hereditary Hemochromatosis, DD11– 008, Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: WReier-Aviles on DSKGBLS3C1PROD with NOTICES Time and Date 11 a.m.–5 p.m., April 12, 2011 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of ‘‘The Association of Genetic Biomarkers and Hereditary Hemochromatosis, DD11– 008, initial review.’’ Contact Person for More Information: Michael Dalmat, DrPH, Scientific Review Officer, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office of the Director, Extramural Research Program Office, 4770 Buford Highway, NE., Mailstop K– 92, Atlanta, GA 30341, Telephone: (770) 488–6423, E-mail: MED1@CDC.GOV. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. VerDate Mar<15>2010 13:45 Jan 20, 2011 Jkt 223001 Office for State, Tribal, Local and Territorial Support (OSTLTS); Correction Correction: This notice was published in the Federal Register on January 4, 2011, Volume 76, Number 2, page 367. The institute office and place should read as follows: Office for State, Tribal, Local and Territorial Support (OSTLTS) Place: CDC, 1600 Clifton Road, NE., Building 19, Atlanta, Georgia 30333. Contact Person for More Information: Kimberly Cantrell, Senior Tribal Liaison for Policy and Evaluation, OSTLTS, CDC, 4770 Buford Highway, MS E–19 Atlanta, Georgia 30341, telephone (404) 498–0411, e-mail: KLW6@cdc.gov. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Dated: January 7, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–1235 Filed 1–20–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Safety and Occupational Health Study Section (SOHSS); National Institute for Occupational Safety and Health (NIOSH); Meeting Notice In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee: PO 00000 Frm 00033 Fmt 4703 Sfmt 9990 Times and Dates 8 a.m.–5 p.m., February 15, 2011 (Closed); 8 a.m.–5 p.m., February 16, 2011 (Closed). Place: Embassy Suites Hotel, 1900 Diagonal Road, Alexandria, Virginia 22314, Telephone: (703) 684–5900, Fax: (703) 684– 1403. Purpose: The Safety and Occupational Health Study Section will review, discuss, and evaluate grant application(s) received in response to the Institute’s standard grants review and funding cycles pertaining to research issues in occupational safety and health, and allied areas. It is the intent of NIOSH to support broadbased research endeavors in keeping with the Institute’s program goals. This will lead to improved understanding and appreciation for the magnitude of the aggregate health burden associated with occupational injuries and illnesses, as well as to support more focused research projects, which will lead to improvements in the delivery of occupational safety and health services, and the prevention of work-related injury and illness. It is anticipated that research funded will promote these program goals. Matters To Be Discussed: The meeting will convene to address matters related to the conduct of Study Section business and for the study section to consider safety and occupational health-related grant applications. These portions of the meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, Centers for Disease Control and Prevention, pursuant to Section 10(d) Public Law 92–463. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Price Connor, PhD, NIOSH Health Scientist, 1600 Clifton Road, NE., Mailstop E–20, Atlanta, Georgia 30333, Telephone: (404) 498–2511, Fax: (404) 498–2571. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Dated: January 7, 2011. Lorenzo J. Falgiano, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–1234 Filed 1–20–11; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\21JAN1.SGM 21JAN1

Agencies

[Federal Register Volume 76, Number 14 (Friday, January 21, 2011)]
[Notices]
[Page 3908]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-1236]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): The Association of Genetic Biomarkers and 
Hereditary Hemochromatosis, DD11-008, Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

Time and Date

    11 a.m.-5 p.m., April 12, 2011 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of ``The Association of Genetic 
Biomarkers and Hereditary Hemochromatosis, DD11-008, initial review.''
    Contact Person for More Information: Michael Dalmat, DrPH, 
Scientific Review Officer, CDC, National Center for Chronic Disease 
Prevention and Health Promotion, Office of the Director, Extramural 
Research Program Office, 4770 Buford Highway, NE., Mailstop K-92, 
Atlanta, GA 30341, Telephone: (770) 488-6423, E-mail: MED1@CDC.GOV.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: January 7, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2011-1236 Filed 1-20-11; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.